|
BC05012b : Colon cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC05012a
Description
| Microarray Panel |
Colonic adenocarcinoma tissue microarray with cancer adjacent normal tissue, containing 59 cases of colon adenocarcinoma, 1 signet ring cell carcinoma, 9 mucinous adenocarcinoma, plus 3 cancer adjacent normal colon tissue, single core per case |
| Cores |
72 |
|
| Cases |
72 |
| Row number |
8 |
| Column number |
9 |
| Core Diameter (mm) |
1 |
| Thickness (µm) |
5 |
| Quality Control |
H&E and IHC confirmed |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: BC05012b
- Availability: In Stock
|
Tags:
Stage (TNM),
With adjacent normal,
Single core per case
- Malignant tumor,
- Malignant tumor (stage I),
- Malignant tumor (stage IA),
- Malignant tumor (stage IIA),
- Malignant tumor (stage IIB),
- Malignant tumor (stage III),
- Malignant tumor (stage IV),
- NAT